Oncology PracticeImmunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019Immuno-oncologyImmunotherapyThrombosisPatient & Survivor CareMelanomaLeukemia, Myelodysplasia, TransplantationALL
Oncology PracticeThe personal cancer vaccine NEO-PV-01 shows promise in metastatic cancersFebruary 1, 2019Immuno-oncologyMelanomaLung CancerGenitourinary Cancer
Oncology PracticeCancer vaccine fails in CRC but trial yields lessonsJanuary 29, 2019GastroenterologyImmuno-oncologyGI OncologyGastrointestinal Cancer
Hematology NewsNovel bispecific CAR shows promise in B-cell malignanciesJanuary 25, 2019Aggressive LymphomasCellular TherapyLymphoma & Plasma Cell DisordersTransplantationImmuno-oncologyImmunotherapyB Cell Lymphoma
Hematology NewsUninterrupted ibrutinib with CAR T could improve CLL outcomesJanuary 25, 2019CLLLeukemia, Myelodysplasia, TransplantationImmunotherapyImmuno-oncologyCellular Therapy
Oncology PracticeAvelumab active in recurrent or refractory ovarian cancerJanuary 24, 2019Gynecologic CancerImmuno-oncology
Oncology PracticePembrolizumab bests chemo in PD-L1-positive esophageal cancerJanuary 23, 2019GastroenterologyImmuno-oncologyGastrointestinal Cancer
Hematology NewsCheckpoint inhibitors linked to rare, but serious immune-related side effectsJanuary 15, 2019Patient & Survivor CareImmuno-oncologyB Cell Lymphoma
Hematology NewsDaily News Special: SABCSJanuary 12, 2019Breast CancerImmuno-oncologyPatient & Survivor Care
Oncology PracticeAdverse events a potential concern for chemotherapy-nivolumab in advanced gastric cancerJanuary 10, 2019Immuno-oncologyGastroenterologyGastrointestinal Cancer
Oncology PracticeNo link between sex and survival on checkpoint inhibitors in latest meta-analysisJanuary 7, 2019Lung CancerImmuno-oncology
Hematology NewsArmored CAR protects T cells, induces remissionsJanuary 4, 2019Cellular TherapyImmuno-oncologyLymphoma & Plasma Cell DisordersCLLAggressive LymphomasImmunotherapyB Cell Lymphoma
Oncology PracticeSevere adverse events seen in placebo arm of cancer clinical trialsDecember 13, 2018Immuno-oncologyRenal Cell Carcinoma
Oncology PracticePD-L1 expression best predicts response to atezolizumab + nab-paclitaxel for mTNBCDecember 5, 2018Breast CancerImmuno-oncology
Oncology PracticeAge-related gene expression may affect responses to RCC therapyDecember 4, 2018Renal Cell CarcinomaImmunotherapyGenitourinary CancerImmuno-oncology
